NO20050396L - Adjuvant viral partikkel - Google Patents

Adjuvant viral partikkel

Info

Publication number: NO20050396L
Authority: NO; Norway
Prior art keywords: vlp; protein; viral particle; virus; immunogen
Prior art date: 2002-07-05

Application number

NO20050396A

Other languages

English (en)

Norwegian (no)

Inventor

Denis Leclerc

Philippe Tessier

Constantio Iii Ro Lopez-Macias

Nathalie Majeau

Original Assignee

Denis Leclerc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-05

Filing date

2005-01-25

Publication date

2005-01-25

2005-01-25 Application filed by Denis Leclerc filed Critical Denis Leclerc

2005-01-25 Publication of NO20050396L publication Critical patent/NO20050396L/no

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/26011—Flexiviridae
- C12N2770/26023—Virus like particles [VLP]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

NO20050396A 2002-07-05 2005-01-25 Adjuvant viral partikkel NO20050396L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US39365902P	2002-07-05	2002-07-05
PCT/CA2003/000985 WO2004004761A2 (en)	2002-07-05	2003-06-30	Adjuvant viral particle

Publications (1)

Publication Number	Publication Date
NO20050396L true NO20050396L (no)	2005-01-25

Family

ID=30115621

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20050396A NO20050396L (no)	2002-07-05	2005-01-25	Adjuvant viral partikkel

Country Status (15)

Country	Link
US (2)	US7641896B2 (ja)
EP (2)	EP2272525A3 (ja)
JP (1)	JP4953570B2 (ja)
KR (1)	KR20050044886A (ja)
CN (1)	CN1665528B (ja)
AU (1)	AU2003281246A1 (ja)
BR (1)	BR0312474A (ja)
CA (1)	CA2434000C (ja)
DK (1)	DK1523329T3 (ja)
ES (1)	ES2431963T3 (ja)
HK (1)	HK1075214A1 (ja)
MX (1)	MXPA05000287A (ja)
NO (1)	NO20050396L (ja)
PT (1)	PT1523329E (ja)
WO (1)	WO2004004761A2 (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8101189B2 (en)	2002-07-05	2012-01-24	Folia Biotech Inc.	Vaccines and immunopotentiating compositions and methods for making and using them
KR20050044886A (ko) *	2002-07-05	2005-05-13	데니스 르클레르	면역보조 바이러스 입자
MX2007003171A (es) *	2004-09-21	2007-05-23	Cytos Biotechnology Ag	Particulas tipo virus que comprenden una proteina de fusion de la proteina de cubierta de ap205 y un polipeptido antigenico.
CN101119749A (zh)	2004-10-25	2008-02-06	赛托斯生物技术公司	肠抑胃肽(gip)抗原阵列及其用途
KR100688522B1 (ko) *	2005-01-18	2007-03-02	삼성전자주식회사	영상데이터 압축기 및 압축방법
US20070041999A1 (en) *	2005-06-01	2007-02-22	Lada Rasochova	Production of multivalent virus like particles
AT503690A1 (de)	2006-06-09	2007-12-15	Biomay Ag	Hypoallergene moleküle
US20100047264A1 (en) *	2006-11-15	2010-02-25	Folia Biotech Inc.	Immunogenic Affinity-Conjugated Antigen Systems Based on Papaya Mosaic Virus and Uses Thereof
DK2069503T3 (da) *	2006-11-15	2016-02-15	Folia Biotech Inc	Papayamosaikvirus-baserede vacciner mod influenza
WO2012048430A1 (en) *	2010-10-14	2012-04-19	Folia Biotech Inc.	Affinity-conjugated nucleoprotein-papaya mosaic virus-like particles and uses thereof
US20100316665A1 (en) *	2007-01-26	2010-12-16	Denis Leclerc	Papaya mosaic virus-based vaccines against salmonella typhi and other enterobacterial pathogens
CA2685308A1 (en) *	2007-04-27	2009-01-29	Dow Global Technologies Inc.	Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
WO2009033276A1 (en) *	2007-09-11	2009-03-19	UNIVERSITé LAVAL	Malva mosaic virus and virus-like particles and uses thereof
CA2728374A1 (en) *	2008-06-17	2010-01-14	Universite Laval	Compositions comprising salmonella porins and uses thereof as adjuvants and vaccines
US20110206727A1 (en) *	2008-07-30	2011-08-25	Denis Leclerc	Multivalent Vaccines Based on Papaya Mosaic Virus and Uses Thereof
WO2012078069A1 (en)	2010-12-09	2012-06-14	Iosif Grigorievich Atabekov	Spherical nano- and microparticles derived from plant viruses for the display of foreign proteins or epitopes
WO2012155261A1 (en) *	2011-05-13	2012-11-22	Folia Biotech Inc.	Papaya mosaic virus compositions and uses thereof for stimulation of the innate immune response
ES2720140T3 (es)	2011-06-09	2019-07-18	Biomay Ag	Proteínas de fusión transportadoras de péptido como vacunas para alergias
WO2013149334A1 (en) *	2012-04-02	2013-10-10	Folia Biotech Inc.	Recombinant papaya mosaic virus coat proteins and uses thereof in influenza vaccines
CA2924819A1 (en) *	2013-09-19	2015-03-26	Folia Biotech Inc.	Papaya mosaic virus and virus-like particles in cancer therapy
US20180153984A1 (en) *	2015-04-30	2018-06-07	The Regents Of The University Of California	Adjuvant particles comprising adenosine receptor antagonists
CA3208643A1 (en)	2021-01-18	2022-07-21	Conserv Bioscience Limited	Coronavirus immunogenic compositions, methods and uses thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL79880A0 (en)	1985-08-29	1986-11-30	Inst Medical W & E Hall	Recombinant virus
US5977438A (en)	1988-02-26	1999-11-02	Biosource Technologies, Inc.	Production of peptides in plants as viral coat protein fusions
DE4006630A1 (de)	1990-03-03	1991-09-12	Behringwerke Ag	Humane monoklonale antikoerper gegen tollwutviren, ihre herstellung und verwendung
DE69128898T2 (de)	1990-08-15	1998-05-28	Therion Biolog Corp	Selbstständig zusammenfügende replikationsdefekte hybride viruspartikel
US5443969A (en) *	1992-10-29	1995-08-22	Rutgers University	RNA packaging system
GB9414118D0 (en)	1994-07-13	1994-08-31	Axis Genetics Ltd	Modified plant viruses as vectors of heterologous peptides
CA2202761A1 (en)	1994-10-18	1996-04-25	Sean Nicholas Chapman	Method of producing a chimeric protein
GB9607899D0 (en)	1996-04-17	1996-06-19	Scottish Crop Research Inst	Virus-like particle
US6042832A (en)	1996-08-28	2000-03-28	Thomas Jefferson University	Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
EP0980257A1 (en) *	1997-05-01	2000-02-23	Chiron Corporation	Use of virus-like particles as adjuvants
US6228368B1 (en)	1997-10-06	2001-05-08	Loyola University Of Chicago	Papilloma virus capsomere formulations and method of use
DE19752855C2 (de)	1997-11-28	2003-04-03	Bundesrepublik Deutschland Let	Retrovirale Pseudotyp-Vektoren mit modifizierten Oberflächen-Hüllproteinen und Verpackungszelle zu ihrer Herstellung für den selektiven Gentransfer
GB9806666D0 (en)	1998-03-27	1998-05-27	Stanley Margaret	Antigen preparation and use
IL140918A0 (en)	1998-07-27	2002-02-10	Genentech Inc	Improved transformation efficiency in phage display through modification of a coat protein
FR2786773B1 (fr)	1998-12-03	2002-03-08	Univ Paris Curie	Proteines d'enveloppe, methodes et utilisations
KR100715954B1 (ko)	1998-12-04	2007-05-09	바이오겐 아이덱 엠에이 인코포레이티드	펩티드 리간드에 의하여 부착된 다중 면역원성 성분을보유한 ｈｂｖ 코어 항원 입자
DE19904800C1 (de)	1999-02-05	2001-02-08	Eberhard Hildt	Partikel zur Gentherapie
GB9921337D0 (en) *	1999-09-09	1999-11-10	Axis Genetics Plc	Modified plant viruses
GB9924351D0 (en) *	1999-10-14	1999-12-15	Brennan Frank	Immunomodulation methods and compositions
GB9924352D0 (en)	1999-10-14	1999-12-15	Hellendoorn Koen	Methods,compositions and applications relating to the generation of novel plant viral particles
US6730306B1 (en)	2000-03-08	2004-05-04	Large Scale Biology Corporation	Parvovirus vaccine as viral coat protein fusions
AUPQ661600A0 (en)	2000-03-31	2000-05-04	Macfarlane Burnet Centre For Medical Research Limited, The	A nucleic acid construct and methods related thereto
IT1317046B1 (it)	2000-06-16	2003-05-26	Ist Superiore Sanita	Proteina di fusione, particelle virali chimeriche che la espongono sulcapside, piante infettate con tali particelle, loro usi e composizioni
WO2002000169A2 (en)	2000-06-26	2002-01-03	The United States Of America, As Represented By The Secretary Of Agriculture	Production of vaccines using transgenic plants
DE60137230D1 (de)	2000-07-06	2009-02-12	Univ Georgetown	Stabile (fixierte) formen von viralen l1 capsidproteinen, deren fusionsproteinen, und deren verwendungen
GB0028319D0 (en) *	2000-11-20	2001-01-03	Univ Southampton	Materials and methods relating to fusion proteins for inducing an immune response
ITRM20010332A1 (it) *	2001-06-11	2002-12-11	Ist Superiore Sanita	Vaccini a subunita' e procedimenti per la loro produzione.
US8101189B2 (en)	2002-07-05	2012-01-24	Folia Biotech Inc.	Vaccines and immunopotentiating compositions and methods for making and using them
KR20050044886A (ko) *	2002-07-05	2005-05-13	데니스 르클레르	면역보조 바이러스 입자

2003
- 2003-06-30 KR KR1020057000114A patent/KR20050044886A/ko not_active Application Discontinuation
- 2003-06-30 JP JP2004518318A patent/JP4953570B2/ja not_active Expired - Fee Related
- 2003-06-30 DK DK03739913.6T patent/DK1523329T3/da active
- 2003-06-30 EP EP10179379A patent/EP2272525A3/en not_active Withdrawn
- 2003-06-30 MX MXPA05000287A patent/MXPA05000287A/es active IP Right Grant
- 2003-06-30 BR BR0312474-6A patent/BR0312474A/pt not_active Application Discontinuation
- 2003-06-30 CA CA2434000A patent/CA2434000C/en not_active Expired - Fee Related
- 2003-06-30 AU AU2003281246A patent/AU2003281246A1/en not_active Abandoned
- 2003-06-30 ES ES03739913T patent/ES2431963T3/es not_active Expired - Lifetime
- 2003-06-30 WO PCT/CA2003/000985 patent/WO2004004761A2/en active Application Filing
- 2003-06-30 CN CN03815935XA patent/CN1665528B/zh not_active Expired - Fee Related
- 2003-06-30 EP EP03739913.6A patent/EP1523329B1/en not_active Expired - Lifetime
- 2003-06-30 PT PT37399136T patent/PT1523329E/pt unknown
- 2003-07-01 US US10/609,417 patent/US7641896B2/en not_active Expired - Fee Related
2005
- 2005-01-25 NO NO20050396A patent/NO20050396L/no not_active Application Discontinuation
- 2005-10-20 HK HK05109287.8A patent/HK1075214A1/xx not_active IP Right Cessation
2009
- 2009-04-03 US US12/384,476 patent/US8282940B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP1523329A2 (en)	2005-04-20
CA2434000C (en)	2012-07-17
CN1665528A (zh)	2005-09-07
EP2272525A3 (en)	2011-11-16
EP1523329B1 (en)	2013-07-24
US8282940B2 (en)	2012-10-09
DK1523329T3 (da)	2013-10-14
JP4953570B2 (ja)	2012-06-13
US7641896B2 (en)	2010-01-05
JP2006504644A (ja)	2006-02-09
EP2272525A2 (en)	2011-01-12
KR20050044886A (ko)	2005-05-13
CN1665528B (zh)	2013-05-15
US20050048082A1 (en)	2005-03-03
WO2004004761A2 (en)	2004-01-15
BR0312474A (pt)	2005-04-26
MXPA05000287A (es)	2005-09-08
US20090280145A1 (en)	2009-11-12
HK1075214A1 (en)	2005-12-09
ES2431963T3 (es)	2013-11-28
PT1523329E (pt)	2013-10-08
CA2434000A1 (en)	2004-01-05
AU2003281246A1 (en)	2004-01-23
WO2004004761A3 (en)	2004-05-06

Legal Events

Date	Code	Title	Description
2007-01-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
NO20050396L (no)	2005-01-25	Adjuvant viral partikkel
DK1450856T3 (da)	2010-05-31	Pakning af immunstimulatorisk CpG i virus-lignende partilker, fremgangsmåde og anvendelse
EA200801756A1 (ru)	2009-02-27	Противогриппозные вакцины, содержащие гемагглютинин и белки матрикса
WO2008014521A3 (en)	2008-12-24	Improved vaccines and methods for using the same
WO2006086188A3 (en)	2006-11-23	Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
DK1294893T3 (da)	2006-07-03	Modifikation af hepatitis B-kerneantigen
CY1110359T1 (el)	2015-04-29	Εμβολια με βαση σιρκοϊους χοιρων
RU2011128371A (ru)	2013-01-20	Модифицированные f протеины sv и способы их применения
EP1200109A4 (en)	2005-06-15	USE OF PEPTIDE NUCLEIC ACID COMPOUNDS TO TRIGGER CELLULAR IMMUNE RESPONSES TO HEPATITIS C
WO2005118626A3 (en)	2006-07-06	Peptides for inducing a ctl and/or htl response to hepatitis c virus
IL164812A0 (en)	2005-12-18	Packaged virus-like particles for use as adjuvants: method of preparation and use
WO2011054011A3 (en)	2011-08-04	Foot and mouth disease virus (fmdv) consensus proteins, coding sequences therefor and vaccines made therefrom
WO2002072036A3 (en)	2003-05-22	Compositions and methods comprising west nile virus polypeptides
AU2002337083A1 (en)	2003-03-24	Vaccinia virus mva-e3l-knockout-mutants and use thereof
ATE267256T1 (de)	2004-06-15	Hepatis e-virus antigene und dessen verwendungen
WO2006024240A3 (es)	2006-06-01	Composición vacunal contra el virus de la hepatitis c.
BR0112020A (pt)	2003-05-13	Partìculas tipo vìrus de bvdv
DK1334197T3 (da)	2011-04-04	Gær-afledt vaccine mod IPNV
SE9903534D0 (sv)	1999-09-30	Vaccin
EP1439856A4 (en)	2005-01-19	RECOMBINANT TOLLWOOD VACCINES AND METHOD FOR THEIR PREPARATION AND USE
DE69922212D1 (de)	2004-12-30	Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
AR041515A1 (es)	2005-05-18	Vacuna a dna contra el virus de papiloma humano
DE60330795D1 (de)	2010-02-11	Impfstoff gegen west nile virus
DE602004028512D1 (de)	2010-09-16	Rekombinante vakzine gegen infektion mit dem japanischen enzephalitis-virus äjevü und verfahren davon
ATE413887T1 (de)	2008-11-15	Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene